lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Fight back. Never yield: Atrial Fibrillation

09 November 2020 - Eyob Gebreyohannes

I was able to witness patients whose stroke could have been prevented with optimisation of the quality of anticoagulation and access to more convenient anticoagulants than warfarin.

I believe it is time to fight back and prevent stroke because of AF. But, hospitals cannot accommodate everyone on a routine basis. In this regard, GPs can play the central role as the primary healthcare setting is a gateway to and the backbone of the healthcare system. I believe by effectively utilising the primary healthcare setting, we can optimise anticoagulation in patients with AF, thereby reducing the incidence and severity of stroke.

Currently, I am doing my PhD at the University of Western Australia. At this time, I have come to realise three things:

  1. AF is causing a substantial burden both in developing countries such as Ethiopia and developed ones such as Australia;
  2. Stroke secondary to AF is preventable; and
  3. GPs can play a central role in reducing the incidence of stroke secondary to AF.

To this end, I plan to conduct a short semi-structured interview with GPs practicing in WA general practices, and hearing the thoughts of GPs is an invaluable critical step in my efforts to optimise anticoagulation management in people with AF. I highly value your willingness and time to share your experiences. As a sign of appreciation, I will be reimbursing you with a $100 gift card. Hence, I humbly invite you to participate in my project. You can find more information in the below linked documents.

Eyob Gebreyohannes

Email: eyob.gebreyohannes@research.uwa.edu.au

 
View the Participant Information Form here.

View the study recruitment materials here. 

Eyob Gebreyohannes
Eyob Gebreyohannes

BPharm, MSc, Ph.D. Candidate

Division of Pharmacy • School of Allied Health

Faculty of Health and Medical Sciences, University of Western Australia 

Related Tags
Related Categories
Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
PCOS - clinical fact sheet and MCQ

Medcast Medical Education Team

Brand icon

Polycystic ovary syndrome (PCOS) affects 10–13% of women, with higher prevalence in certain ethnic groups. It is characterized by hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology. PCOS increases the risk of type 2 diabetes, cardiovascular disease, and requires early diagnosis and personalized management to reduce long-term effects. This FastTrack-CPD provides a clinical summary on the management of PCOS with a quiz to apply your learning and receive CPD (RP and EA categories).

5 mins READ
Chalazion - clinical fact sheet and MCQ

Medcast Medical Education Team

Brand icon

A chalazion is a painless, chronic eyelid swelling caused by a blocked meibomian gland, leading to granulomatous inflammation. It can persist for weeks to months and is more common in adults. Risk factors include blepharitis, ocular rosacea, and seborrhoeic dermatitis. This FastTrack-CPD provides a clinical summary on the management of chalazion with a quiz to apply your learning and receive CPD (RP and EA categories).

Acne - clinical fact sheet and MCQ

Medcast Medical Education Team

Brand icon

Acne is a chronic inflammatory condition of the pilosebaceous unit, triggered by androgen sensitivity rather than elevated levels. It commonly affects adolescents and young adults, with males experiencing more severe cases. Beyond skin symptoms, acne can impact mental health, requiring consideration of emotional and social effects in patient management. This FastTrack-CPD provides a clinical summary on the management of acne with a quiz to apply your learning and receive CPD (RP and EA categories).

5 mins READ